Page 58 - Army Contracting Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Army contracting command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Army Contracting Command Today - Breaking & Trending Today

Pentagon awards OTA for online AI marketplace -- FCW

By Lauren C. Williams

The Defense Department has taken a major first step in creating an online marketplace for artificial intelligence acquisition.
The Joint Artificial Intelligence Center with Army Contracting Command awarded Indiana Innovation Institute (IN3) an other transaction agreement for an undisclosed amount on Jan. 20 to build and manage an online environment for the rapid procurement and delivery of AI capabilities for DOD.
The online portal prototype will be created through Tradewind, a specialized business model for AI acquisitions that aims to give startups and academic institutions a direct line to the government and make it easier for DOD to buy commercially available technology as part of a “collaborative ecosystem”, according to the Feb. 1 announcement. ....

United States , William Roberts , Marlo Abrahamson , Laurenc Williams , College Park , Artificial Intelligence Center , University Of Maryland , University Of Delaware , Howard University , Indiana Innovation Institute , Booz Allen Hamilton , Defense Department , Army Contracting , Joint Artificial Intelligence Center , Army Contracting Command , Defense Systems , ஒன்றுபட்டது மாநிலங்களில் , வில்லியம் ராபர்ட்ஸ் , கல்லூரி பூங்கா , செயற்கை உளவுத்துறை மையம் , பல்கலைக்கழகம் ஆஃப் மேரிலாந்து , பல்கலைக்கழகம் ஆஃப் டெலாவேர் , ஹோவர்ட் பல்கலைக்கழகம் , இந்தியானா கண்டுபிடிப்பு நிறுவனம் , பூஸ் ஆலன் ஹாமில்டன் , பாதுகாப்பு துறை ,

HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment

HHS, DOD collaborate with Merck to continue the development and large-scale manufacturing of investigational COVID-19 treatment
The U.S. Department of the Health and Human Services (HHS) and the Department of Defense (DOD) jointly announced an agreement with Merck to support advanced development and large-scale manufacturing of the their investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical COVID-19.
The investigational therapeutic is a promising first-in-class fusion protein and immune modulator. Immune modulators have the potential to minimize the damaging effects of an overactive immune response to COVID-19. This overactive response can contribute to the severity of the illness. ....

United States , Alex Azar , Department Of Defense , Us Department Of The Health , Biomedical Advanced Research , Human Services , Drug Administration , Program Executive Office For Chemical , Development Authority , Army Contracting Command , Department Of Health , Office Of The , Nuclear Defense , Operation Warp Speed , President Trump , Operation Warp Speed Supported , Assistant Secretary , Program Executive Office , Emergency Use Authorization , ஒன்றுபட்டது மாநிலங்களில் , அலெக்ஸ் அசார் , துறை ஆஃப் பாதுகாப்பு , எங்களுக்கு துறை ஆஃப் தி ஆரோக்கியம் , மனிதன் சேவைகள் , ப்ரோக்ர்யாம் நிர்வாகி அலுவலகம் க்கு இரசாயன , வளர்ச்சி அதிகாரம் ,

HHS, Pentagon Collaborate With Merck to Continue Development and Large-Scale Manufacturing of Investigational COVID-19 Treatment

U.S. Department of Defense
Department of the Health and Human Services (HHS) and the Department of Defense (DOD) jointly announced an agreement with Merck to support advanced development and large-scale manufacturing of the their investigational therapeutic MK-7110 to treat hospitalized patients with severe or critical COVID-19.
The investigational therapeutic is a promising first-in-class fusion protein and immune modulator.
Immune modulators have the potential to minimize the damaging effects of an overactive immune response to COVID-19.
This overactive response can contribute to the severity of the illness.
“Our agreement with Merck is the latest example of how industry and government are coming together under Operation Warp Speed to move potential therapeutics all the way from development through to manufacturing, enabling faster distribution,” said HHS Secretary Alex Azar. ....

United States , Alex Azar , Department Of Defense , Biomedical Advanced Research , Human Services , Drug Administration , Program Executive Office For Chemical , Development Authority , Department Of The Health , Army Contracting Command , Department Of Health , Office Of The , Nuclear Defense , Operation Warp Speed , President Trump , Operation Warp Speed Supported , Assistant Secretary , Program Executive Office , Emergency Use Authorization , ஒன்றுபட்டது மாநிலங்களில் , அலெக்ஸ் அசார் , துறை ஆஃப் பாதுகாப்பு , மனிதன் சேவைகள் , ப்ரோக்ர்யாம் நிர்வாகி அலுவலகம் க்கு இரசாயன , வளர்ச்சி அதிகாரம் , துறை ஆஃப் தி ஆரோக்கியம் ,

Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer

Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Pfizer
The Trump Administration, through the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD), will purchase an additional 100 million doses of COVID-19 vaccine from Pfizer.
On Dec. 11, the U.S. Food and Drug Administration (FDA) authorized the vaccine for emergency use and doses began shipping immediately. The vaccine is being provided at no cost to Americans. Vaccine administration costs for private-sector administration partners are covered by healthcare payers: private insurance, Medicare or Medicaid, and HHS’s program to cover COVID-19 costs for the uninsured which is reimbursing the provider at Medicare rates from the provider relief fund. ....

United States , New Jersey , Alex Azar , Us Department Of Health , Human Services , Department Of Defense , Biomedical Advanced Research , Trump Administration , Drug Administration , Program Executive Office For Chemical , Development Authority , Department Of Health , Office Of The , Nuclear Defense , Army Contracting , Operation Warp Speed , Emergency Use Authorization , Assistant Secretary , Program Executive Office , Army Contracting Command , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜெர்சி , அலெக்ஸ் அசார் , எங்களுக்கு துறை ஆஃப் ஆரோக்கியம் , மனிதன் சேவைகள் , துறை ஆஃப் பாதுகாப்பு ,

Special Storage and Adverse Reactions for First COVID-19 Vaccine Approved by the FDA

Limitations and Safety Concerns of the Pfizer Vaccine
The FDA s Advisory Committee on Immunization Practices (ACIP) panelists met Dec. 11 and recommended approval of the vaccine for those age 16 and older. The panel said clinicians need more guidance on whether to use the vaccine on pregnant or breastfeeding women, the immunocompromised, those who have a history of allergies and those under age 16.
The FDA-issued healthcare provider information sheet on the vaccine said there is not enough data to recommend vaccinating those women or the immunocompromised, and also advises against giving the vaccine to individuals who have a history of serious allergic reaction to any component of the vaccine. ....

United States , Alex Azar , Janssen Johnson , National Institute Of Allergy , Dod Joint Program Executive Office For Chemical , Pfizer Inc , Nuclear Defense , Biologics Advisory Committee , National Institutes Of Health , Biomedical Advanced Research , Human Services , Us Department Of Health , Drug Administration , Advisory Committee On Immunization Practices , Development Authority , Office Of The , Products Advisory Committee , Army Contracting , Related Biologics Advisory Committee , Operation Warp Speed , Multiple Dose Vials , Safety Concerns , Pfizer Vaccine , Immunization Practices , May See , Assistant Secretary ,